| Medical and Health Sciences | Lifetime | 115 | US 64 | 99.99 |
| Philosophy, Ethics and Religion | Lifetime | 39 | US 18 | 99.78 |
| Psychology and Behavioral Sciences | Lifetime | 870 | US 539 | 99.64 |
| Medical and Health Sciences | 2021-2025 | 677 | US 230 | 99.85 |
| Psychology and Behavioral Sciences | 2021-2025 | 792 | US 289 | 97.88 |
| Psychiatry and Mental health | Lifetime | 8 | US 7 | 99.98 |
| Philosophy of Mind, Language and Cognitive Science | Lifetime | 6 | US 3 | 99.90 |
| Clinical Pharmacology | Lifetime | 164 | US 73 | 99.34 |
| Clinical Psychology | Lifetime | 636 | US 408 | 99.15 |
| Pediatrics, Perinatology and Child Health | Lifetime | 686 | US 338 | 97.84 |
| Clinical Neurology | Lifetime | 649 | US 286 | 96.78 |
| Biological Psychiatry | Lifetime | 69 | US 32 | 95.75 |
| Applied Psychology | Lifetime | 279 | US 162 | 95.94 |
| Family Practice | Lifetime | 195 | US 92 | 85.01 |
| Psychiatry and Mental health | 2021-2025 | 26 | US 11 | 99.73 |
| Clinical Psychology | 2021-2025 | 645 | US 252 | 93.31 |
| Clinical Pharmacology | 2021-2025 | 278 | US 79 | 89.25 |
| Applied Psychology | 2021-2025 | 123 | US 42 | 88.54 |
| Schizophrenia research and treatment | Lifetime | 2 | US 1 | 99.98 |
| Pharmaceutical studies and practices | Lifetime | 4 | US 4 | 99.84 |
| Bipolar Disorder and Treatment | Lifetime | 6 | US 4 | 99.92 |
| Mental Health and Psychiatry | Lifetime | 5 | US 2 | 99.92 |
| Treatment of Major Depression | Lifetime | 16 | US 11 | 99.79 |
| Electroconvulsive Therapy Studies | Lifetime | 9 | US 6 | 99.67 |
| Tryptophan and brain disorders | Lifetime | 57 | US 26 | 99.60 |
| Obsessive-Compulsive Spectrum Disorders | Lifetime | 37 | US 26 | 99.44 |
| Pharmaceutical Practices and Patient Outcomes | Lifetime | 69 | US 35 | 99.00 |
| Health Systems, Economic Evaluations, Quality of Life | Lifetime | 195 | US 98 | 99.36 |
| Digital Mental Health Interventions | Lifetime | 45 | US 15 | 99.15 |
| Healthcare Decision-Making and Restraints | Lifetime | 38 | US 21 | 98.65 |
| Mobile Health and mHealth Applications | Lifetime | 86 | US 42 | 98.80 |
| Attention Deficit Hyperactivity Disorder | Lifetime | 146 | US 92 | 98.75 |
| Parkinson's Disease and Spinal Disorders | Lifetime | 20 | US 6 | 98.69 |
| Mental Health Treatment and Access | Lifetime | 255 | US 104 | 98.76 |
| Synthesis and Characterization of Heterocyclic Compounds | Lifetime | 371 | US 60 | 97.46 |
| Parkinson's Disease Mechanisms and Treatments | Lifetime | 617 | US 222 | 98.06 |
| Cardiovascular Syncope and Autonomic Disorders | Lifetime | 276 | US 126 | 97.31 |
| Adolescent and Pediatric Healthcare | Lifetime | 360 | US 196 | 96.90 |
| Epilepsy research and treatment | Lifetime | 695 | US 285 | 97.25 |
| Mental Health Research Topics | Lifetime | 544 | US 302 | 97.50 |
| Medication Adherence and Compliance | Lifetime | 298 | US 182 | 95.84 |
| Psychiatric care and mental health services | Lifetime | 258 | US 62 | 96.18 |
| Telemedicine and Telehealth Implementation | Lifetime | 345 | US 165 | 93.68 |
| Mental Health and Patient Involvement | Lifetime | 513 | US 159 | 93.46 |
| Family Caregiving in Mental Illness | Lifetime | 631 | US 215 | 88.10 |
| Social Media in Health Education | Lifetime | 650 | US 343 | 85.69 |
| Pathogenesis and Treatment of Hiccups | Lifetime | 165 | US 66 | 84.22 |
| Mental Health via Writing | Lifetime | 319 | US 147 | 79.82 |
| Schizophrenia research and treatment | 2021-2025 | 9 | US 2 | 99.70 |
| Bipolar Disorder and Treatment | 2021-2025 | 13 | US 2 | 99.07 |
| Tryptophan and brain disorders | 2021-2025 | 86 | US 19 | 97.38 |
| Mental Health and Psychiatry | 2021-2025 | 31 | US 10 | 97.05 |
| Treatment of Major Depression | 2021-2025 | 109 | US 34 | 95.22 |
| Mental Health Treatment and Access | 2021-2025 | 294 | US 65 | 93.66 |
| Neurotransmitter Receptor Influence on Behavior | 2021-2025 | 174 | US 91 | 91.91 |
| Digital Mental Health Interventions | 2021-2025 | 343 | US 101 | 91.73 |
| Obsessive-Compulsive Spectrum Disorders | 2021-2025 | 195 | US 69 | 91.33 |
| Pharmaceutical studies and practices | 2021-2025 | 278 | US 97 | 87.42 |
| Electroconvulsive Therapy Studies | 2021-2025 | 614 | US 157 | 62.60 |
| Psychiatric care and mental health services | 2021-2025 | 767 | US 79 | 54.84 |
| Pharmacovigilance and Adverse Drug Reactions | 2021-2025 | 852 | US 126 | 51.66 |
| Mental Health via Writing | 2021-2025 | 867 | US 225 | 39.90 |